Concepedia

James Goodhand

JG

Statistics

Publications

53

Citations

4.2K

H-Index

30

Active since

2009

Affiliations

Royal Devon & Exeter NHS Foundation Trust(Current)

University of Exeter

Queen Mary University of London

Western General Hospital

Guy's and St Thomas' NHS Foundation Trust

James Goodhand is an author at Royal Devon & Exeter NHS Foundation Trust specializing in inflammatory bowel disease, medicine, and immunology.

Publications per year

2009–2025

53

Publications

53

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · The Lancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD

Nicholas A. Kennedy, Simeng Lin, James Goodhand et al. · Gut · 2021 · 280 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors

James Goodhand, Mahmood Wahed, Joel Mawdsley et al. · Inflammatory Bowel Diseases · 2012 · 234 citations

Medicine, Clinical Sciences, Psychology +15

Association of Genetic Variants in <i>NUDT15</i> With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

G Walker, Graham Heap, Michiel Voskuil et al. · JAMA · 2019 · 171 citations · Full text

Life Sciences, Genetics, Pharmacology +17

1–5 of 53